Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 715, Issue 1-3, Pages 238-245Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2013.05.015
Keywords
Morphine; Oxycodone; Fentanyl; Withdrawal syndrome; Naloxonazine; Naloxone methiodide
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Grants-in-Aid for Scientific Research [25430076] Funding Source: KAKEN
Ask authors/readers for more resources
Withdrawal syndrome after the cessation of mu-opioid receptor agonists remains an obstacle in the clinical treatment of pain. There is limited information available on the mechanisms that underlie the expression of the withdrawal signs of opioids, and especially regarding the involvement of mu-opioid receptor subtypes and the location of the responsible opioid receptors. Therefore, the present study was designed to determine the mechanism of the expression of withdrawal signs in mu-opioid receptor agonist-dependent mice. Morphine-, oxycodone- and fentanyl-dependent mice showed a marked loss of body-weight and other signs of withdrawal after a naloxone challenge. Interestingly, the phenotype of the withdrawal signs for morphine and oxycodone was different from that of fentanyl. Furthermore, pretreatment with naloxonazine (so-called mu(1)-opioid receptor antagonist), did not significantly alter the withdrawal signs precipitated by naloxone in these mu-opioid receptor agonist-dependent mice, whereas the peripherally limited opioid receptor antagonist naloxone methiodide significantly increased the loss of body-weight accompanied by diarrhea, indicating that a peripheral naloxonazine-insensitive site for opioid receptors, as an adaptation mechanism, plays an important role in the expression of at least the loss of body-weight. On the other hand, i.c.v. treatment with naloxone methiodide potently induced jumping behavior and trembling in morphine-dependent mice. These results indicate that the prolonged activation of supraspinal mu-opioid receptors plays a role in most of the physical dependence induced by mu-opioid receptor agonists in mice. Thus, the withdrawal symptoms observed after the cessation of mu-opioid receptor agonists are distinctly regulated though supraspinal and peripheral naloxonazine-insensitive sites of mu-opioid receptors. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available